|
PLSCR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.436810E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.275600E-01 |
| Normal-vs-Stage2 |
1.075160E-03 |
| Normal-vs-Stage3 |
4.352800E-01 |
| Normal-vs-Stage4 |
4.293800E-01 |
| Stage1-vs-Stage2 |
5.399700E-03 |
| Stage1-vs-Stage3 |
9.976200E-01 |
| Stage1-vs-Stage4 |
8.690000E-01 |
| Stage2-vs-Stage3 |
1.974320E-02 |
| Stage2-vs-Stage4 |
4.180300E-02 |
| Stage3-vs-Stage4 |
8.933200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.182400E-01 |
| Normal-vs-AfricanAmerican |
2.555800E-01 |
| Normal-vs-Asian |
8.625400E-01 |
| Caucasian-vs-AfricanAmerican |
4.426000E-01 |
| Caucasian-vs-Asian |
7.804000E-01 |
| AfricanAmerican-vs-Asian |
4.265800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.017020E-01 |
| Normal-vs-Female |
2.227800E-01 |
| Male-vs-Female |
4.164200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.258000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.964000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.981200E-03 |
| Normal-vs-Age(81-100Yrs) |
9.278200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.912400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.415500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.468600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.782810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.924200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.932000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.208820E-01 |
| Classical-VS-Follicular |
2.22044604925031E-15 |
| Classical-VS-Other |
2.129600E-01 |
| Classical-VS-Normal |
9.988600E-01 |
| Tall-VS-Follicular |
3.66600000000217E-05 |
| Tall-VS-Other |
1.047020E-01 |
| Tall-VS-Normal |
2.165600E-01 |
| Follicular-VS-Other |
2.248000E-01 |
| Follicular-VS-Normal |
1.67890001900872E-09 |
| Other-VS-Normal |
1.126190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.412040E-02 |
| Normal-vs-N1 |
9.003400E-01 |
| N0-vs-N1 |
4.081500E-02 |
|
|
